Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Evaluating Anticancer Effects of Bisphosphonates in Myeloma
Orlando, Florida / December 4-7, 2010
Orlando - Bisphosphonates have demonstrated efficacy for preventing skeletal-related events in multiple myeloma and other cancers. Beyond the beneficial bone effects, evidence had emerged to suggest that nitrogen-containing bisphosphonates...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Expanding Iron Chelation Applications: New Data on Organ Protection
Orlando, Florida / December 4-7, 2010
Orlando - The role of iron chelators, long employed in thalassemia, was supported in an expanding list of both malignant and non-malignant hematological diseases in a series of studies presented at ASH. The ability of iron chelators to...
MEDICAL FRONTIERS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Greater Prophylaxis from Venous Thromboembolism for Cancer Patients
Orlando, Florida / December 4-7, 2010
Orlando - The more than twofold increase in rates of venous thromboembolism (VTE) in cancer patients over a recent 5-year period has identified a growing crisis in comprehensive care of patients with malignancy. The causes of the rising...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Validating the Subcutaneous Route in Multiple Myeloma Maintenance Therapy
Orlando, Florida / December 4-7, 2010
Orlando - New phase III data demonstrating that subcutaneous (s.c.) administration of a drug commonly administered intravenously (i.v.) is as effective but better tolerated in the treatment of multiple myeloma (MM) has been proposed as a...
RESOURCE LINE
VACCINE
October-December 2010
Broadening HPV vaccination to boys, men Elbasha E, Dasbach E. Impact of vaccinating boys and men against HPV in the United States. Vaccine 2010;28:6858-67. Kim J. Targeted human papillomavirus vaccination of men who have sex with men in...
PRIORITY PRESS - 35th Congress of the European Society of Medical Oncology
Advances in the Treatment of Lung and Breast Cancer
Milan, Italy / October 8-12, 2010
Milan - The treatment of non-small-cell lung cancer (NSCLC) and breast cancer, 2 of the most common cancers worldwide, has a promising future, as delegates in Milan heard this week. NSCLC, accounting for around 85% of lung cancers, can now...
PRIORITY PRESS - 26th International Papillomavirus Conference
Reducing the Burden of HPV-related Disease in Men and Women
Montreal, Quebec / July 3-8, 2010
According to Dr. Suzanne Garland, Director, Microbiological Research, Royal Women’s Hospital, Melbourne, Australia, genital warts (GWs) are the most common condition seen in sexual health services in the country. Multiple visits are...
FRONTLINE - Hematology/Oncology
Evolving Standards of Therapy in Multiple Myeloma
June 2010
Reviewed and edited by: Kevin W
PRIORITY PRESS - 23rd International Symposium on Supportive Care in Cancer
New Data in the Prevention of CINV
Vancouver, British Columbia / June 24-26, 2010
Vancouver - Prior to the modern era of emetic prophylaxis, chemotherapy-induced nausea and vomiting (CINV) was one of the most worrisome side effects from chemotherapy. Significant improvement has been achieved since the introduction of...